Trade Summary

5 days ago, MANCHESTER KEITH S, serving as Dir at Roivant Sciences Ltd. (ROIV), sold 1,638,163 shares at $34.46 per share, for a total transaction value of $56,444,075.76. Following this transaction, MANCHESTER KEITH S now holds 1,748,403 shares of ROIV.

This sale represents a 48.37% decrease in MANCHESTER KEITH S's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, June 26, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, July 1, 2026 (accepted Jun 30, 8:38 PM ET), 5 days after the trade was made.

Roivant Sciences Ltd. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.